| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal lipoprotein metabolism in diabetic nephropathy
|
Hirano, Tsutomu
|
|
2013
|
18 |
2 |
p. 206-209
|
artikel
|
| 2 |
APOE polymorphism and diabetic nephropathy
|
Araki, Shin-ichi
|
|
2013
|
18 |
2 |
p. 230-233
|
artikel
|
| 3 |
Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia
|
Matsunaga, Akira
|
|
2014
|
18 |
2 |
p. 220-224
|
artikel
|
| 4 |
A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy
|
Stratikos, Efstratios
|
|
2013
|
18 |
2 |
p. 225-229
|
artikel
|
| 5 |
Beneficial effect of LDL-apheresis in refractory nephrotic syndrome
|
Muso, Eri
|
|
2014
|
18 |
2 |
p. 286-290
|
artikel
|
| 6 |
Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease
|
Rye, Kerry-Anne
|
|
2013
|
18 |
2 |
p. 247-250
|
artikel
|
| 7 |
Causes and consequences of lipoprotein(a) abnormalities in kidney disease
|
Kronenberg, Florian
|
|
2013
|
18 |
2 |
p. 234-237
|
artikel
|
| 8 |
Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency
|
Hirashio, Shuma
|
|
2013
|
18 |
2 |
p. 189-193
|
artikel
|
| 9 |
Characteristics and 3-year mortality and infection rates among incident hemodialysis patients with a permanent catheter undergoing a first vascular access conversion
|
Ng, Yee-Yung
|
|
2013
|
18 |
2 |
p. 329-338
|
artikel
|
| 10 |
Chronic kidney disease induced dysfunction of high density lipoprotein
|
Yamamoto, Suguru
|
|
2013
|
18 |
2 |
p. 251-254
|
artikel
|
| 11 |
Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy
|
Kamei, Daigo
|
|
2013
|
18 |
2 |
p. 320-328
|
artikel
|
| 12 |
Do statins play a role in renoprotection?
|
Kasahara, Masato
|
|
2013
|
18 |
2 |
p. 282-285
|
artikel
|
| 13 |
Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs
|
Campese, Vito M.
|
|
2014
|
18 |
2 |
p. 291-295
|
artikel
|
| 14 |
Epidemiology of dyslipidemia in chronic kidney disease
|
Iseki, Kunitoshi
|
|
2014
|
18 |
2 |
p. 185-188
|
artikel
|
| 15 |
Fabry disease: experience of screening dialysis patients for Fabry disease
|
Kusano, Eiji
|
|
2013
|
18 |
2 |
p. 269-273
|
artikel
|
| 16 |
Genetic associations in diabetic nephropathy
|
Mooyaart, Antien L.
|
|
2013
|
18 |
2 |
p. 197-200
|
artikel
|
| 17 |
History of Kawasaki disease
|
Kawasaki, Tomisaku
|
|
2014
|
18 |
2 |
p. 301-304
|
artikel
|
| 18 |
Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy
|
Koya, Daisuke
|
|
2013
|
18 |
2 |
p. 210-213
|
artikel
|
| 19 |
In vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease
|
Ikewaki, Katsunori
|
|
2013
|
18 |
2 |
p. 261-264
|
artikel
|
| 20 |
Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency
|
Shimizu, Miho
|
|
2013
|
18 |
2 |
p. 305-312
|
artikel
|
| 21 |
Knee extensor muscle strength and index of renal function associated with an exercise capacity of 5 metabolic equivalents in male chronic heart failure patients with chronic kidney disease
|
Hotta, Chiharu
|
|
2013
|
18 |
2 |
p. 313-319
|
artikel
|
| 22 |
Lipoprotein glomerulopathy in China
|
Chen, Yuqing
|
|
2013
|
18 |
2 |
p. 218-219
|
artikel
|
| 23 |
Lipoprotein metabolism and CKD: overview
|
Barter, Philip
|
|
2013
|
18 |
2 |
p. 243-246
|
artikel
|
| 24 |
Pathology of glomerular lipidosis
|
Sato, Hiroshi
|
|
2013
|
18 |
2 |
p. 194-196
|
artikel
|
| 25 |
Results of the 4D study: ten years of follow-up?
|
Wanner, Christoph
|
|
2013
|
18 |
2 |
p. 274-277
|
artikel
|
| 26 |
Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease
|
Vaziri, Nosratola D.
|
|
2013
|
18 |
2 |
p. 265-268
|
artikel
|
| 27 |
Serum lipids and prevention of atherosclerotic cardiovascular events in hemodialysis patients
|
Shoji, Tetsuo
|
|
2013
|
18 |
2 |
p. 257-260
|
artikel
|
| 28 |
Statins in chronic kidney disease: what do meta-analyses tell us?
|
Upadhyay, Ashish
|
|
2013
|
18 |
2 |
p. 278-281
|
artikel
|
| 29 |
The Asia Pacific Meeting for Vasculitis and ANCA Workshop 2012: surgical treatment for Takayasu’s arteritis
|
Miyata, Tetsuro
|
|
2013
|
18 |
2 |
p. 296-300
|
artikel
|
| 30 |
The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease
|
Madhavan, Sethu M.
|
|
2013
|
18 |
2 |
p. 238-242
|
artikel
|
| 31 |
The kidney and lipids: preface
|
Kasiske, Bertram
|
|
2014
|
18 |
2 |
p. 180-184
|
artikel
|
| 32 |
The role of lipids and uremic toxins in cardiovascular disease in CKD
|
Massy, Ziad A.
|
|
2013
|
18 |
2 |
p. 255-256
|
artikel
|
| 33 |
Topics in lipoprotein glomerulopathy: an overview
|
Saito, Takao
|
|
2013
|
18 |
2 |
p. 214-217
|
artikel
|
| 34 |
Treatment and impact of dyslipidemia in diabetic nephropathy
|
Toyama, Tadashi
|
|
2013
|
18 |
2 |
p. 201-205
|
artikel
|
| 35 |
World Congress of Nephrology (WCN) 2013 Satellite Symposium “Kidney and Lipids”, June 5–7, 2013, Fukuoka, Japan
|
|
|
2014
|
18 |
2 |
p. 179
|
artikel
|
Tijdschrift beschrijving